Reviewed by PillSeek Editorial Team · Last updated
About This Medication
This medication is a Yellow;brown Capsule 19 mm, Capsule with imprint "R2666". It contains Gabapentin 300 mg; of Gabapentin[gabapentin];. This belongs to the Decreased central nervous system disorganized electrical activity pharmacologic class. It is manufactured by Aphena Pharma Solutions - Tennessee, LLC. For details please contact your physician.
Basic Information
- Imprint
- R2666
- Color
- Yellow;brown
- Shape
- Capsule
- Size
- 19 mm
Drug Information
- Strength
- Gabapentin 300 mg;
- Dosage Form
- Capsule
Pharmaceutical Classification
- Pharmacologic Class
- Decreased central nervous system disorganized electrical activity
Related Medications
Other drugs in the same class: Decreased Central Nervous System Disorganized Electrical Activity
- GabapentinGabapentin 100 mg;WHITE;WHITE • CAPSULE
- GabapentinGABAPENTIN 100 mg;WHITE • CAPSULE
- GabapentinGabapentin 300 mg;WHITE;YELLOW • CAPSULE
- GabapentinGABAPENTIN 300 mg;YELLOW • CAPSULE
- GabapentinGabapentin 400 mg;WHITE;ORANGE • CAPSULE
- GabapentinGABAPENTIN 400 mg;ORANGE • CAPSULE
- GabapentinGabapentin 600 mg;WHITE • OVAL
- GabapentinGABAPENTIN 600 mg;WHITE • CAPSULE
- GabapentinGabapentin 800 mg;WHITE • OVAL
- GabapentinGABAPENTIN 800 mg;WHITE • CAPSULE
Ingredients
- Active Ingredients
- Gabapentin[gabapentin];
- Inactive Ingredients
- Ferrosoferric oxide;starch, corn;d&c yellow no. 10;fd&c blue no. 2;fd&c red no. 40;gelatin;mannitol;shellac;propylene glycol;ferric oxide red;fd&c blue no. 1;sodium lauryl sulfate;talc;titanium dioxide;ferric oxide yellow;silicon dioxide;
Additional Information
- Manufacturer
- Aphena Pharma Solutions - Tennessee, LLC
- Status (Rx/OTC)
- Rx
- Brand Names
- Gabarone, Gralise, Horizant, Neurontin
Browse Related Pills
⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.